| Released | Contributor | Author | Title | Pages | Price |
| 27-Nov-2009 | Pechala's Reports | Lubomir Pechala | CORTEX PHARMACEUTICALS INC (COR=US) 2-weeks forecast | 1 |
$10 |
| 26-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for BIOTECHNOLOGY | 18 |
$49 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: CORTEX PHARMACEU -- COR | 1 |
$4 |
| 26-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: ALXA , ALTH , ARIA , COR , DEPO , ISTA , PTIE , QCOR -- DRUGS | 3 |
$4 |
| 23-Nov-2009 | RiskMetrics Group |
N/A
| ISS Report on Cortex Pharmaceuticals, Inc. | 9 |
$135 |
| 23-Nov-2009 | Reuters Investment Profile |
N/A
| Cortex Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 | 569 |
$299 |
| 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) | 71 |
$199 |
| 23-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for COR | 13 |
$25 |
| 15-Nov-2009 | Graham & Whiteside Limited | Graham & Whiteside | BOLIVIA - Public ENERGY Companies - Graham & Whiteside listing | 4 |
$40 |
1.48% Nasdaq 
Research Reports
